Scott M. Giacobello
Chief Financial Officer, GW PHARMACEUTICALS PLC.
Companies
- Whitehawk Therapeutics, Inc.Chief financial officer Nov 29, 2021 to now1
- Whitehawk Therapeutics, Inc.Chief executive officer Apr 4, 2023 to Apr 4, 20232
- Whitehawk Therapeutics, Inc.President Apr 4, 2023 to Apr 4, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Whitehawk Therapeutics, Inc. WHWK333,489 shares3$1.0M at $3.06May 14, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 14, 2026Granted 38,265 shares at $3.92 of Whitehawk Therapeutics, Inc.3
- Apr 16, 2026Sold 141,600 shares at $4.13 of Whitehawk Therapeutics, Inc.4
- Apr 15, 2026Sold 77,000 shares at $3.86 of Whitehawk Therapeutics, Inc.4
- Apr 1, 2026Exercised options 473,902 shares of Whitehawk Therapeutics, Inc.5
- Mar 2, 2026Sold 2,594 shares at $3.31 of Whitehawk Therapeutics, Inc.6
- Mar 1, 2026Exercised options 6,750 shares of Whitehawk Therapeutics, Inc.6
- Mar 3, 2025Sold 2,806 shares at $2.35 of Whitehawk Therapeutics, Inc.7
- Mar 1, 2025Exercised options 6,750 shares of Whitehawk Therapeutics, Inc.7
- Sep 26, 2022Granted 20,000 shares at $12.50 of Whitehawk Therapeutics, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Apr 17, 2026
- 5SEC EDGARForm 4 filed Apr 3, 2026
- 6SEC EDGARForm 4 filed Mar 10, 2026
- 7SEC EDGARForm 4 filed Mar 3, 2025
- 8SEC EDGARForm 4 filed Sep 27, 2022